The Use of Non-Human Primates in the Development and Production of Poliomyelitis Vaccines

Advisory Committee to the Surgeon General (1959). Second report of the Committee on Live Polio Virus Vaccine. Public Health Service, Department of Health, Education and Welfare, Washington, DC

Anonymous (1969). World Medical News 10, (October 17), 11

Anonymous (1978). Polio vaccine requires a boost. New Scientist 78, 430

Beale A.J. (1978). Use of Tissue cultures for testing vaccines. J. Roy. Soc. Med. 71, 681–686

Bittle J.L. , Avampato J. , Amundsen S.M. , and Vickers J.H. (1966). Results of testing production costs of oral polio virus vaccine. J. Infect. Dis. 116, 215–220

Bodian D. (1958). Control of the manufacture of poliomyelitis vaccine. In Poliomyelitis: Papers and Discussions presented at the Fourth International Poliomyelitis Conference, pp. 77–85. J.B. Lippincott Co. Philadelphia

Boulger L.R. (1973). The neurovirulence test for live poliomyelitis vaccine. J. Biol. Stand. 1, 119–138

Boulger L.R. , and Magrath D.T. (1973). Differing neurovirulence of three Sabin attenuated type 3 vaccine seed pools and the progeny. J. Biol. Stand. 1, 139–147

Boulger L.R. , and Perkins F.T. (1967). The effect of the route of inoculation and species of monkey on the sensitivity of the neurovirulence test. Symposium Series in Immunobiological Standardization, Vol 2, pp. 117–132. Karger, Basel

Caba SSO V.J. , Junghern E.L. , Levine S. , Moyer A.W. , Roca Garcia M. , and Cox H.R. (1960). Assessment of correlation between certain in vitro polio virus markers and monkey neurovirulence. Br. Med. J.ii(5193), 188–191

Conway W.G. (1965). The availability and long term supply of primates for medical research. Lab. Primate Newsletter 4, 1–8

Department of Health and Social Security (1977). Compendium of licensing requirements for the manufacture of biological medicinal products. Department of Health and Social Security London

Dudgeon J.A. (1969). Immunisation against rubella. Nature 223, 674–676

Eddy B.E. , Borman G.S. , Berkeley W.H. , and Young R.D. (1961). Tumors induced in hamsters by infection of rhesus monkey kidney cell extracts. Proc. Soc. Exp. Biol. Med. 107, 191–197

Enders J.F. , Weller T.H. , and Robbins F.C. (1949). Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissue. Science 109, 85–87

European Pharmacopoeia (1971). Vaccinum poliomyelitis inactivum. Vol. II, pp. 413–415. Maisoneuve Saint Ruffine

Fisher P.J. (1967). The Polio Story. Heinemann London

Hayflick L. (1969). A consideration of the cell substrates used in human virus vaccine propagation. Progress in Immunobiological Standardization (ed. Regamey R.H. , Hennessen W. , Ikic D. , Ungar J. ) Vol. 3, pp. 86–93.3. S. Karger Basel

Hayflick L. , and Moorhead P.S. (1961). The serial cultivation of human diploid cell strains. Exp. Cell. Res. 25, 585–621

Hobbs K.R. (1975). Report on the Commission of European Communities on the supply and use of non-human primates for biomedical research in the member countries of the European Economic Community. Committee on Medical and Public Health Research, Commission of the European Communities, Brussels

Hobbs K.R. , and Bleby J. (1976). Laboratory non-human primates for biomedical research in the United Kingdom. Medical Research Council Laboratory Animals Centre London

Home Office, (1978). Experiments on living animals - Statistics, 1977. Cmd. paper No. 7333. (See Table 8). Her Majesty's Stationery Office London

Institute for Laboratory Animal Resources (1975). Non-human primates: Usage and and availability for biomedical programs. Institute for Laboratory Animal Resources, National Academy of Sciences, Washington, DC

Interagency Primate Steering Committee (1977). Draft National Primate Plan. Interagency Primate Steering Committee, NIH, Department of Health, Education and Welfare Washington, DC

International Comparative Study (1973). An international comparative Study of the methods of performing and assessing the neurovirulence test for live attenuated polio virus in monkeys. J. Biol. Stand. 1, 149–164

Landsteiner K. , and Popper E. (1908). Mikroscopische Praparate von einem menslichen und zwei Afftenruchenmarken. Wien Klin. Wochschr. 21, 1830

Landsteiner K. , and Popper E. (1909). Ubertragung der poliomyelitis acute auf Affen. Z. Immunforsch. u. Exp. Ther. 2, 377–390

LeCornu A.P. , and Rowan A.N. (1978). Trends in the use of non-human primates in biomedical programs. Lab. Animals 12, 235–242

Mahouy C.B. (1977). Organization of primate research facilities in France. Use of non-human primates in biomedical research (ed. Prasad M.R.N. , and Anand Kumar T.C. ), pp. 416–421. Indian National Science Academy New Delhi

Meyer H.M. , Perkman P.D. , and Panon T.C. (1966). Attenuated rubella virus. II. Production of an experimental live virus vaccine and clinical trial. New England J. Med. 274, 575–580

Muckenhirn N. (1975). Trends in primate imports into the United States. ILAR News 18, 3, 2

Muckenhirn N. (1976). Trends in primate imports into the United States. ILAR NEWS 19, 3, 3

Muckenhirn N. (1977). Trends in primate imports into the United States. ILAR NEWS 20, 3, 5

Nakano J.H. , Hatch M.H. , Thieme M.L. , and Nottay B. (1978). Parameters for differentiating vaccine-derived and wild polio virus strains. Progress in Medical Virology (ed. Melnick J. ) Vol. 24, pp. 178–206. Sikarger Basel

Nathanson N. , and Langmuir A.D. (1963). The Cutter incident: Poliomyelitis following formaldehyde - inactivated polio virus vaccination in the United States during the Spring of 1955. Am. J. Hyg. 78, 16–81

National Foundation for Infantile Paralysis (1953). Immunologic classification of poliomyelitis viruses. VII. Discussion of results and general summary of the cooperative program for the typing of two hundred and thirty strains. Am. J. Hyg. 58, 74–80

Pagano J.S. , Bottiger M. , and Gard S. (1963). Chart type 1 attenuated polio virus vaccine prepared on human diploid cells: a study in 135 Swedish children. I. Epidemiology and results of trial. European Association against Poliomyelitis and allied diseases, Vol. 8, pp. 498–507. Masson and Cie Paris

Paul J.R. (1971). A history of poliomyelitis. Yale University Press: New Haven

Petricciani J.C. , Hopps H.E. , Elizberg B.L. , and Harley E.H. (1977): Application of in vitro systems to public health. The Future of Animals, Cells, Models and Systems in Research, Development, Education and Testing, pp. 240–254. National Academy of Sciences Washington, DC

Rhodes A.J. , Wood W. , and Duncan D. (1955). The present place of virus laboratory tests in the diagnosis of poliomyelitis. Poliomyelitis, pp. 237–267. WHO Monograph Series No. 26, WHO: Geneva

Sabin A.B. (1965). Oral polio virus vaccine: History of its development and prospects for eradication of poliomyelitis. J. Am. Med. Ass. 194, 872–876

Sabin A.B. , Hennessen W. , and Winsser J. (1954). Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types. J. Exp. Med. 99, 551–576

Sabin A.B. , and Olitsky P.K. (1936). Cultivation of polio virus in vitro in human embryonic nervous tissue. Proc. Soc. Exp. Biol. Med. 34, 357–359

Salk J.E. (1952). Immunologic classification of the poliomyelitis virus. Poliomyelitis: Papers and Discussions presented at the Second International Poliomyelitis Conference, pp. 188–193. J.B. Lippincott and Co. Philadelphia

Salk J.E. (1953). Studies In human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress. J.Am. Med. Ass. 151, 1081–1098

Spiegel A. (1977). Primate report, number 1. Committee on Medical and Public Health Research, Commission of European Communities. Brussels

Spiegel A. (1978). Primate Report, number 2. Committee on Medical and Public Health Research, Commission of European Communities. Brussels

Sweet B.H. , and Hilleman M.R. (1960). The vacuolating virus, SV40. Proc. Soc. Exp. Biol. Med. 105, 420–427

Syverton J.T. , Scherer W.F. , and Buterac C. (1957). Propagation of poliomyelitis virus in cultures of monkey and human testicular tissues. Proc. Soc. Exp. Biol. Med. 7, 23–28

Technical Committee on Poliomyelitis Vaccine and Subcommittee on the Monkey Safety Test (1956). The monkey safety test for poliomyelitis vaccine. Am. J. Hyg. 64, 104–137

U.S. Department of Commerce (1948). US Imports, annotated by country (FT-110 Annual). United States Department of Commerce, Bureau of Census: Washington, DC

U.S. Department of Health, Education and Welfare (1954). Minimum requirements - poliomyelitis vaccine. Public Health Service (NIH), U.S. DHEW, Bethesda

U.S. Public Health Service (1956). Regulations. Biologic products - additional standards - poliomyelitis vaccine. Code of Federal Regulations, Title 21, p. 4922

Van Wezel A.L. (1972). New Trends in the preparation of cell substrates for the production of virus vaccines. Progress in Immunobiological Standardization (ed. Regamey R.H. , Perkins F.T. ) Vol. 5, pp. 187–192, S. Karger Basel

Walcroft M.J. (1979). Primates - Requirements by the pharmaceutical industry. Primates in Medicine (ed. Moor-Jankowski J. , and Held J. ), (in press). S. Karger Basel

Weber H. (1979). Major trends in the use of primate animals in Western Europe. Primates in Medicine (ed. Moor-Jankowski J. , and Held J. ), (in press). S. Karger Basel

Weller T.H. (1953). The application of tissue culture methods to the study of poliomyelitis. New Engl. J. Med. 249, 186–195

Whitaker A.M. (1978). Application of cell culture methods to virology. The Pharmaceutical Application of Cell Techniques, pp. 25–30. Universities' Federation for Animal Welfare. Potters Bar London

Wilson J.R. (1963). Margins of safety. Collins London

Younger J.S. , Ward E.N. , and Salk J.E. (1952). Studies of poliomyelitis viruses in cultures of monkey testicular tissue. I. Propagation of virus in roller tubes. Am. J. Hyg. 55, 291–300